跳至主要内容
临床试验/NCT03776188
NCT03776188已完成不适用

Prospective Registry for Trans-Orifice Endoscopic Suturing Applications

American Gastroenterological Association11 个研究点 分布在 1 个国家目标入组 204 人开始时间: 2018年10月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
204
试验地点
11
主要终点
Excess Weight Loss

研究概览

简要总结

To determine patient outcomes (survival, additional endoscopic or surgical procedures) with an endoscopic suturing technique at predetermined intervals compared to historical controls when applicable.

To evaluate the efficacy, safety, and durability of trans-orifice endoscopic suturing therapy for revision of bariatric procedures as well as study the safety, efficacy, and durability of preventative fixation of GI endoprosthetics.

详细描述

To determine patient outcomes (survival, morbidity including hospitalization, additional re-interventions with radiologic, endoscopic or surgical procedures) with endoscopic suturing at predetermined intervals from the last endoscopic suturing procedure or at failure of the endoscopic suturing with conversion to another intervention such as surgery and compared to historical controls when applicable.

To evaluate the efficacy and safety of endoscopic suturing therapy in preventative fixation of stents and bariatric revision.

To collect data on the common use endoscopic suturing therapy in other indications.

This prospective clinical study is a real-world registry and not a randomized controlled trial. Given the conditions commonly treated with endoscopic suturing and the potential lack of equivalent expertise in open, laparoscopic, and trans-oral surgical procedures at all centers, randomization of participants is not possible nor ethical. In addition, there are clinical scenarios where endoscopic therapy with surgical sutures, tissue sealants, and/or endoprosthetics may be appropriate and open and laparoscopic surgical approaches inappropriate from an ethical viewpoint. Given the multitude of currently available minimally invasive approaches to repair, it would be unethical to expose and randomize patients who are suitable for more minimally invasive approaches to a more invasive and inherently more morbid approach.

This outcomes study is external to the subject receiving the medical device treatment. Subjects will receive the medical device treatment regardless of study participation and the surgery is not part of this research. Subjects will be consented prior to their procedure, to obtain basic follow-up information. If the subject provides informed consent to participate in the registry, then site staff will follow the participant's clinical data for the period of the registry. Site staff may also contact the subject(s) during their standard clinic visit or via the telephone and obtain information on: overall health, specific events related to any subsequent surgical, endoscopic, or radiologic interventions, and hospitalizations.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Selected to undergo trans-orifice suturing prior to study enrollment
  • Age 18+ years
  • Patient ASA classification I, II, III, including emergency cases
  • Patient willing to provide informed consent, cooperate with post-operative recommendations and follow-up assessment

排除标准

  • Patients who do not meet the clinical criteria for trans-orifice suturing
  • Under age 18 years
  • ASA classification IV
  • Unable to provide informed consent
  • Unable to participate in follow-up assessments
  • Uncorrectable coagulopathy at the time of endoscopic suturing
  • Any terminal disease that limits patient's survival to less than one year

结局指标

主要结局

Excess Weight Loss

时间窗: Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months

Changes in body weight measured in kilograms subsequent to the revisional procedure will be summarized using statistics both in percentage terms using the % excess weight lost and absolute terms.

Migration Rate of Stent - sutures

时间窗: Change at 2 weeks, 30 days, 3 months

Number of intact Sutures

Dislocation of Stent - location

时间窗: Change at 2 weeks, 30 days, 3 months

Change in the position measured using location. Location options: Bridging the GJ anastomosis, Confined to gastric lumen, Bridging the pylorus, Bridging Lower Esophageal Sphincter

Migration Rate of Stent - removal

时间窗: Change at 2 weeks, 30 days, 3 months

Days to removal and replacement

Total Weight Loss

时间窗: Measured at 2 weeks, 30 days, 3 months, 6 months, 12 months

Changes in body weight measured in kilograms subsequent to the revisional procedure will be summarized using statistics both in percentage terms using the % total weight loss and absolute terms.

Dislocation of Stent - distance

时间窗: Change at 2 weeks, 30 days, 3 months

Change in the position measured using distance (centimeters).

Migration Rate of Stent - placement

时间窗: Change at 2 weeks, 30 days, 3 months

Distal from placement over time (yes or no)

Migration Rate of Stent - replaced

时间窗: Change at 2 weeks, 30 days, 3 months

Stent replaced or re-structured over time (yes or no)

次要结局

未报告次要终点

研究者

发起方
American Gastroenterological Association
申办方类型
Other
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验

Endoscopic Suturing (ES) Registry | 临床试验